Richard Marais

Top papers

• Mutations of the BRAF gene in human cancer

  Helen Davies, Graham R. Bignell, Charles Cox, et al.·2002·Nature
  ↗ 10,637OA
• Mechanism of Activation of the RAF-ERK Signaling Pathway by Oncogenic Mutations of B-RAF

  Paul Wan, Mathew J. Garnett, S. Mark Roe, et al.·2004·Cell
  ↗ 2,792OA
• Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tumor Progression through CRAF

  Sonja J. Heidorn, Carla Milagre, Steven R. Whittaker, et al.·2010·Cell
  ↗ 1,462OA
• Melanoma biology and new targeted therapy

  Vanessa C. Gray‐Schopfer, Claudia Wellbrock, Richard Marais·2007·Nature
  ↗ 1,374
• The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain

  Richard Marais, Judy Wynne, Richard Treisman·1993·Cell
  ↗ 1,294
• The RAF proteins take centre stage

  Claudia Wellbrock, Maria Karasarides, Richard Marais·2004·Nature Reviews Molecular Cell Biology
  ↗ 1,200
• Cyclooxygenase-Dependent Tumor Growth through Evasion of Immunity

  Santiago Zelenay, Annemarthe G. van der Veen, Jan P. Böttcher, et al.·2015·Cell
  ↗ 1,094OA
• <i>RAS</i> Mutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF Inhibitors

  Fei Su, Amaya Virós, Carla Milagre, et al.·2012·New England Journal of Medicine
  ↗ 1,021OA
• The role of signaling pathways in the development and treatment of hepatocellular carcinoma

  Steven R. Whittaker, Richard Marais, Andrew X. Zhu·2010·Oncogene
  ↗ 822OA
• Guilty as charged

  Mathew J. Garnett, Richard Marais·2004·Cancer Cell
  ↗ 792OA
• Activation of the Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Pathway by Conventional, Novel, and Atypical Protein Kinase C Isotypes

  Dorothee C. Schönwaßer, Richard Marais, Christopher J. Marshall, et al.·1998·Molecular and Cellular Biology
  ↗ 760OA
• Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis

  Tim Eisen, T. Ahmad, Keith T. Flaherty, et al.·2006·British Journal of Cancer
  ↗ 636OA